| AHI | active hostility index; Animal Health Institute; apnea-plus-hypopnea index |
|---|---|
| CONPA-DRI | III conpa-dri I plus intensified doxorubicin |
| DM-R | decayed plus missing teeth, minus replaced teeth |
| 4E | four-plus edema |
| FPG | fasting plasma glucose; fluorescence plus Giemsa; focal proliferative glomerulonephritis |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
|---|---|
| audiovisual aids | Auditory and visual instructional materials. (12 Dec 1998) |
| communication aids for disabled | Equipment that provides mentally or physically disabled persons, who cannot speak effectively, with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesisers. The output of such aids includes written words, artificial speech, language signs, morse code, and pictures. (12 Dec 1998) |
| hearing aids | Devices which amplify sound to help persons with hearing loss. (12 Dec 1998) |
| lymphoma, aids-related | B-cell lymphoid tumours that occur in association with aids. Patients often present with an advanced stage of disease and highly malignant subtypes including burkitt lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumours are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in aids is a complex result of ebv infection, HIV antigenic stimulation, and T-cell-dependent HIV activation. (12 Dec 1998) |